Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 104
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Occup Med (Lond) ; 67(6): 435-441, 2017 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-28637219

RESUMEN

BACKGROUND: Injury prevention is an important issue for police officers, but the effectiveness of prevention initiatives is dependent on officers' motivation toward, and adherence to, recommended health and safety guidelines. AIMS: To understand effects of police officers' motivation to prevent occupational injury on beliefs about safety and adherence to injury prevention behaviours. METHODS: Full-time police officers completed a survey comprising validated psychometric scales to assess autonomous, controlled and amotivated forms of motivation (Treatment Self-Regulation Questionnaire), behavioural adherence (Self-reported Treatment Adherence Scale) and beliefs (Safety Attitude Questionnaire) with respect to injury prevention behaviours. RESULTS: There were 207 participants; response rate was 87%. Hierarchical multiple regression analyses demonstrated that autonomous motivation was positively related to behavioural adherence, commitment to safety and prioritizing injury prevention. Controlled motivation was a positive predictor of safety communication barriers. Amotivation was positively associated with fatalism regarding injury prevention, safety violation and worry. CONCLUSIONS: These findings are consistent with the tenets of self-determination theory in that autonomous motivation was a positive predictor of adaptive safety beliefs and adherence to injury prevention behaviours.


Asunto(s)
Motivación , Traumatismos Ocupacionales/prevención & control , Policia/psicología , Adulto , Actitud , China , Femenino , Humanos , Masculino , Persona de Mediana Edad , Traumatismos Ocupacionales/psicología , Psicometría , Encuestas y Cuestionarios
2.
BJOG ; 126(13): 1523, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31495043

Asunto(s)
Parto , Femenino , Humanos , Embarazo
3.
J Neonatal Perinatal Med ; 16(3): 453-459, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37718866

RESUMEN

BACKGROUND: Current American Academy of Pediatrics guidelines recommend discharge at physiologic maturity regardless of weight; however, our institution's neonatal ICU policy requires a minimum weight of 1800 g for discharge even when infant is physiologically mature. So, we wanted to determine if discharge at physiologic maturity (PM), based on national guidelines, would decrease hospital days (HD). METHODS: We reviewed 129 infants with birthweight 1300g- 1800 g. Data were analyzed by paired t-test/ Wilcoxon-rank-sum test. RESULTS: Age at discharge vs. age at PM was 0.55d per infant higher (P-value 0.033) resulting in 71 total HD. For SGA babies, this difference was 1.47d vs 0.19d in non-SGA babies (P- value 0.0243) and this difference was an average of 2.63d (P-value < 0.001) for those who reached PM < 1800 g, contributing to 50 of 71 HD potentially saved. CONCLUSION: There was a 0.55-2.6-day difference between age at discharge and age at PM, greater in SGA infants and infants who reached PM prior to 1800 g. There might be an opportunity to send infants home earlier to their families if there is no minimum weight required.

4.
J Neonatal Perinatal Med ; 14(1): 53-60, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-32804105

RESUMEN

BACKGROUND: Oxygen toxicity mediated by reactive oxygen species (ROS) plays an essential role in the development of bronchopulmonary dysplasia in premature infants. By reducing oxidative stress, antioxidants protect the immature lung. We studied the effects of MnTBAP, a catalytic antioxidant on angiogenesis and alveolar growth following neonatal hyperoxia. METHODS: Newborn mouse litters randomized to room air (RA) or >95% O2 for 72 hours from day 4 (D4) to D7 to receive either MnTBAP (10 mg/kg/d) or saline intraperitoneally (every 24 h for three doses). Lungs harvested for angiogenic gene expression, protein expression, and histopathology post-hyperoxia exposure. Radial alveolar count (RAC), mean linear intercept (MLI) and vessel density assessed by histopathology. RESULTS: Angiogenic gene expression was significantly lower in the hyperoxia group compared to the RA group. The protein expression for VEGF and its receptor, VEGFR1, was significantly lower following treatment with MnTBAP compared to hyperoxia alone. Expression of VEGFR2, Angiopoietin-1 and TIE2, were substantially higher in the RA groups compared to hyperoxia groups with or without MnTBAP. Hyperoxia groups demonstrated alveolar simplification. MnTBAP reduced vessel density and failed to improve alveolar growth following hyperoxia. CONCLUSIONS: MnTBAP, a catalytic antioxidant, does not offer protection from hyperoxia-induced alveolar impairment. The lack of angiogenic upregulation by MnTBAP may contribute to alveolar simplification in newborn mice.


Asunto(s)
Antioxidantes/uso terapéutico , Displasia Broncopulmonar/tratamiento farmacológico , Lesión Pulmonar/tratamiento farmacológico , Metaloporfirinas/uso terapéutico , Animales , Animales Recién Nacidos , Displasia Broncopulmonar/metabolismo , Modelos Animales de Enfermedad , Lesión Pulmonar/metabolismo , Metaloporfirinas/clasificación , Ratones , Neovascularización Fisiológica/efectos de los fármacos
5.
J Neonatal Perinatal Med ; 13(2): 175-182, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31744017

RESUMEN

BACKGROUND: We aimed to investigate whether the change in methemoglobin levels (ΔMHb) predicts oxygenation response to inhaled nitric oxide (iNO) in persistent pulmonary hypertension of the newborn (PPHN) with lung disease, with or without pulmonary hypoplasia. METHODS: In this prospective observational study, infants were categorized based on ΔMHb and oxygenation response (ΔPaO2/FiO2) following iNO: ΔMHb ≤0 or ΔMHb>0, and ΔPaO2/FiO2 < 20 mmHg (Non-responder) or≥20 mmHg (Responder). ΔMHb levels were compared among infants with or without pulmonary hypoplasia. RESULTS: Among infants with pulmonary hypoplasia (n = 28), ΔMHb was not associated with an oxygenation response to iNO or survival without ECMO. Among infants without hypoplasia (n = 29), subjects with ΔMHb>0 following iNO (n = 21) had a greater ΔPaO2/FiO2 (median, 64 mmHg; IQR, 127; p < 0.01) and 100% survival without extracorporeal membrane oxygenation (ECMO) when compared to infants with ΔMHb ≤0 (n = 8; median 10 mmHg; IQR, 33). CONCLUSIONS: PPHN secondary to lung disease without hypoplasia with increased ΔMHb following iNO was associated with better oxygenation response and survival without ECMO compared to subjects without an increase in MHb.


Asunto(s)
Factores Relajantes Endotelio-Dependientes/uso terapéutico , Metahemoglobina/metabolismo , Óxido Nítrico/uso terapéutico , Síndrome de Circulación Fetal Persistente/tratamiento farmacológico , Administración por Inhalación , Femenino , Hernias Diafragmáticas Congénitas/complicaciones , Humanos , Recién Nacido , Riñón/anomalías , Pulmón/anomalías , Masculino , Síndrome de Aspiración de Meconio/complicaciones , Oligohidramnios , Síndrome de Circulación Fetal Persistente/sangre , Síndrome de Circulación Fetal Persistente/complicaciones , Neumonía/complicaciones , Embarazo , Pronóstico , Estudios Prospectivos , Síndrome de Dificultad Respiratoria del Recién Nacido/complicaciones
6.
Gene Ther ; 16(3): 329-39, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19177133

RESUMEN

The efficacy of current anti-cancer gene therapies is limited by the inability of gene vectors to penetrate the poorly vascularized, hypoxic regions of tumors, leaving these sites untreated. We describe a new approach for targeting gene therapy to these sites, which employs an attenuated strain of the non-pathogenic bacterium, Salmonella typhimurium, carrying an exogenous (that is, reporter or therapeutic) gene under the regulation of a new, highly hypoxia-inducible promoter (FF+20(*)). This bacterial vector was seen to rapidly migrate into, and thrive in, hypoxic areas of both mammary tumor spheroids grown in vitro and orthotopic mammary tumors after systemic injection. Using the reporter gene construct, FF+20(*)-lacZ, we show that bacterial expression of high levels of beta-galactosidase occurred only in hypoxic/necrotic sites of spheroids and tumors. We then replaced the reporter gene with one encoding a novel cytotoxic protein (HlyE) and showed that this was also expressed by bacteria only in hypoxic regions of murine mammary tumors. This resulted in a marked increase in tumor necrosis and reduced tumor growth. Our system represents a promising new strategy for delivering gene therapy to poorly vascularized regions of tumors and shows, for the first time, the efficacy of HlyE as an anti-tumor agent.


Asunto(s)
Terapia Genética/métodos , Vectores Genéticos/farmacocinética , Neoplasias Mamarias Experimentales/terapia , Salmonella typhimurium/genética , Animales , Muerte Celular , Hipoxia de la Célula/fisiología , Técnicas de Cocultivo , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Femenino , Marcación de Gen , Genes Reporteros , Proteínas Hemolisinas/genética , Proteínas Hemolisinas/metabolismo , Neoplasias Mamarias Experimentales/metabolismo , Neoplasias Mamarias Experimentales/patología , Ratones , Ratones Endogámicos BALB C , Mutagénesis Sitio-Dirigida , Necrosis , Esferoides Celulares , Distribución Tisular , Células Tumorales Cultivadas
7.
J Autism Dev Disord ; 48(11): 3773-3782, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29948531

RESUMEN

The objective of this retrospective analysis of the longitudinal Millennium Cohort Study was to examine whether maternal alcohol consumption in pregnancy (MACP) is associated with the development of childhood autism spectrum disorders (ASD). Data on MACP and ASD were obtained from parental questionnaires. There were 18,168 singleton mother-child pairs with data on MACP, and 12,595 answered the question on ASD when the children were 11 years old. No statistically significant association was found between MACP and ASD for light (OR 0.78, 95% CI 0.48-1.29), moderate (OR 0.89, 95% CI 0.35-2.27), or heavy (OR 1.54, 95% CI 0.56-4.21) MACP. Alcohol consumption during pregnancy was not associated with the risk of developing ASD in this study cohort.


Asunto(s)
Consumo de Bebidas Alcohólicas/epidemiología , Trastorno del Espectro Autista/epidemiología , Efectos Tardíos de la Exposición Prenatal/epidemiología , Adulto , Niño , Preescolar , Femenino , Humanos , Masculino , Embarazo
8.
Schizophr Res ; 202: 369-377, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30031616

RESUMEN

BACKGROUND: Psychological and pharmacological treatments have been shown to reduce rates of transition to psychosis in Ultra High Risk (UHR) young people. However, social functioning deficits have been unresponsive to current treatments. AIMS: The study aims were to: i) describe the theoretical basis and therapeutic targets of a novel intervention targeting social functioning in UHR young people; and ii) examine its acceptability, safety and preliminary effect on social functioning. METHODS: An international, multidisciplinary team developed a new intervention (MOMENTUM) to improve social functioning in UHR young people. MOMENTUM blends two novel approaches to social recovery: strengths and mindfulness-based intervention embedded within a social media environment, and application of the self-determination theory of motivation. The acceptability and safety of MOMENTUM were tested through a 2-month pilot study with 14 UHR participants. RESULTS: System usage was high, with over 70% of users being actively engaged over the trial. All participants reported a positive experience using MOMENTUM, considered it safe and would recommend it to others. 93% reported it to be helpful. There were large, reliable improvements in social functioning (d = 1.83, p < 0.001) and subjective wellbeing (d = 0.75, p = 0.03) at follow-up. There were significant increases in the mechanisms targeted by the intervention including strengths usage (d = 0.70, p = 0.03), mindfulness skills (d = 0.66, p = 0.04) and components of social support. Social functioning improvement was significantly correlated with indicators of system usage. CONCLUSION: MOMENTUM is engaging and safe. MOMENTUM appeared to engage the hypothesized mechanisms and showed promise as a new avenue to improve social functioning in UHR young people.


Asunto(s)
Internet , Atención Plena/métodos , Evaluación de Procesos y Resultados en Atención de Salud , Aceptación de la Atención de Salud , Satisfacción del Paciente , Trastornos Psicóticos/rehabilitación , Autoeficacia , Red Social , Apoyo Social , Terapia Socioambiental/métodos , Adolescente , Adulto , Femenino , Humanos , Masculino , Proyectos Piloto , Riesgo , Adulto Joven
9.
J Perinatol ; 27(8): 490-5, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17625574

RESUMEN

OBJECTIVE: To evaluate the prevalence of hereditary prothrombotic mutations, and their effect on the incidence and severity of umbilical arterial or venous catheter (UAC or UVC)-associated thrombosis. STUDY DESIGN: All neonates with a UAC or UVC were studied prospectively for the presence, severity and timing of thrombosis with duplex Doppler ultrasound scan. Genetic testing for factor V Leiden (FVL), prothrombin mutation (PTm) and methylene-tetrahydrofolate reductase (MTHFR) mutations was performed using PCR and restriction fragment length polymorphism assays. RESULT: Umbilical catheter (UC)-associated thrombosis developed in 16/53 (31%) neonates; 23% of UACs and 22% of UVCs were associated with thrombosis. The prevalence of a significant prothrombotic mutation was present in 10/51 (20%) of infants: FVL (8%), MTHFR667 homozygosity (10%), MTHFR1298 homozygosity (2%) and PTm (0%). There was no increase in the risk of UC-associated thrombus in patients carrying these prothrombotic mutations; our study had the power to detect a 2.5-fold increased risk of thrombosis for any of these significant mutations. In addition, MTHFR667 heterozygosity was found in 41% of infants and MTHFR1298 heterozygosity in 52% and also were not associated with increased risk of UC-associated thrombus. The risk of MTHFR double heterozygosity (db het) was 14%, the risk of a significant or db het was 17/51 (33%) and the risk of any mutation was 90%. CONCLUSION: Prothrombotic genetic mutations are common in our Neonatal Intensive Care Unit population but do not appear to increase the risk of UC-associated thrombosis.


Asunto(s)
Catéteres de Permanencia/efectos adversos , Factor V/genética , Recién Nacido/fisiología , Protrombina/genética , Trombosis/etiología , Trombosis de la Vena/etiología , Femenino , Heterocigoto , Humanos , Masculino , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Estudios Prospectivos , Trombosis/diagnóstico por imagen , Trombosis/genética , Ultrasonografía Doppler Dúplex , Arterias Umbilicales , Venas Umbilicales
10.
J Perinatol ; 27(4): 214-9, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17330053

RESUMEN

OBJECTIVE: Characteristics of preterm infants who develop pulmonary hypertension (PHT) and their response to inhaled nitric oxide (iNO) are not well described. Our objective was to identify risk factors for PHT in infants <37 weeks gestational age (GA) and to evaluate their response to iNO. STUDY DESIGN: A retrospective chart review was conducted in infants <37 weeks GA born from July/2000 to October/2005 who had an echocardiographic diagnosis of PHT in the first 4 weeks of life. A comparison non-PHT group was generated matched for GA and birth date. Data on prenatal and postnatal characteristics, response to iNO and mortality were collected. RESULTS: Low Apgar scores, preterm premature rupture of membranes, oligohydramnios, pulmonary hypoplasia and sepsis were independently predictive of PHT. Mortality was significantly higher in the PHT group (26.2% versus 4.1%; P<0.0001) compared to the control group. Low birth weight, severe intraventricular hemorrhage and male sex were significantly associated with death in infants with PHT. Thirty-seven percent (23/61) of infants with PHT were treated with inhaled NO. Infants < 29-week GA had poor response to iNO and the response to iNO increased with GA (P<0.02). CONCLUSIONS: Low Apgar scores, oligohydramnios and pulmonary hypoplasia are associated with the development of PHT in premature infants. The percentage of infants responding to iNO increases with advancing GA.


Asunto(s)
Broncodilatadores/administración & dosificación , Hipertensión Pulmonar/etiología , Enfermedades del Prematuro/etiología , Óxido Nítrico/administración & dosificación , Administración por Inhalación , Puntaje de Apgar , Peso al Nacer , Presión Sanguínea , Femenino , Rotura Prematura de Membranas Fetales , Edad Gestacional , Humanos , Hipertensión Pulmonar/tratamiento farmacológico , Hipertensión Pulmonar/mortalidad , Recién Nacido , Recien Nacido Prematuro , Enfermedades del Prematuro/tratamiento farmacológico , Enfermedades del Prematuro/mortalidad , Unidades de Cuidado Intensivo Neonatal , Modelos Logísticos , Pulmón/anomalías , Masculino , Oligohidramnios , Embarazo , Estudios Retrospectivos , Factores de Riesgo , Sepsis/complicaciones
11.
J Perinatol ; 26(6): 378-80, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16724080

RESUMEN

We present a full-term male infant who presented with tachypnea and an increased band count on his complete blood count (CBC) with an immature to total neutrophil (I:T) ratio of 0.6 raising suspicion of early onset sepsis. A blood culture was drawn and he was started on appropriate antibiotics. The patient's clinical condition rapidly improved; however, the white cell count 'left shift' persisted. When a detailed family history was obtained, it was discovered that the father, paternal uncle and the grandfather had been diagnosed with Pelger-Huet anomaly (PHA). As the urine, blood and CSF cultures were all negative in this now well-appearing infant, the left shift on the CBC was believed to be due to inheritance of the PHA. We present this case to emphasize that even in this age of sophisticated laboratory evaluation, a good clinical history, including family history, and clinical evaluation, are essential for accurate diagnosis.


Asunto(s)
Recuento de Leucocitos , Neutrófilos/patología , Anomalía de Pelger-Huët/diagnóstico , Sepsis/diagnóstico , Errores Diagnósticos , Humanos , Recién Nacido , Masculino , Neutrófilos/ultraestructura , Anomalía de Pelger-Huët/sangre , Anomalía de Pelger-Huët/genética
12.
Pain ; 111(1-2): 30-7, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15327806

RESUMEN

This study examined the cellular actions of the anti-migraine drug sumatriptan, on neurons in the substantia gelatinosa of the spinal trigeminal nucleus pars caudalis. Sumatriptan inhibited the miniature EPSC (mEPSC) rate in a dose dependent fashion, with an EC(50) of 250 nM. Sumatriptan (3 microM) inhibited the mEPSC rate by 36%, without altering the mEPSC amplitude. This effect was partially reversed by the 5HT(1D) specific antagonist BRL15572 (10 microM). In contrast, the 5HT(1B) agonist CP93129 (10 microm) did not alter the mEPSC rate. Furthermore, sumatriptan (3 microM) decreased the amplitude of electrically evoked EPSCs (eEPSC) by 40%. After incubating the slices in ketanserin (an antagonist which shows selectivity for 5HT(1D) over 5HT(1B) receptors) sumatriptan had little effect on eEPSC amplitude. In control conditions paired stimuli resulted in paired pulse depression (PPD; the ratio eEPSC(2)/eEPSC(1)=0.7+/-0.01), whilst in the presence of sumatriptan the PPD was blocked (ratio eEPSC(2)/eEPSC(1)=0.9+/-0.1). Sumatriptan produced no post-synaptic membrane current and had no significant effect on membrane conductance over a range of membrane potentials (-60 to -130 mV). RT-PCR experiments revealed the presence of mRNA for both 5HT(1D) and 5HT(1B) receptor subtypes in the trigeminal ganglia and subnucleus caudalis. These data suggest that sumatriptan acts pre-synaptically on trigeminal primary afferent central terminals to reduce the probability of release of glutamate, and that this action is mediated through 5HT(1D) receptors.


Asunto(s)
Agonistas de Receptores de Serotonina/farmacología , Sustancia Gelatinosa/efectos de los fármacos , Sumatriptán/farmacología , Núcleo Caudal del Trigémino/efectos de los fármacos , Animales , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Técnicas de Placa-Clamp , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley , Receptor de Serotonina 5-HT1B/genética , Receptor de Serotonina 5-HT1D/genética , Sustancia Gelatinosa/citología , Sustancia Gelatinosa/fisiología , Núcleo Caudal del Trigémino/citología , Núcleo Caudal del Trigémino/fisiología
13.
Psychol Bull ; 125(6): 627-68; discussion 692-700, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10589297

RESUMEN

A meta-analysis of 128 studies examined the effects of extrinsic rewards on intrinsic motivation. As predicted, engagement-contingent, completion-contingent, and performance-contingent rewards significantly undermined free-choice intrinsic motivation (d = -0.40, -0.36, and -0.28, respectively), as did all rewards, all tangible rewards, and all expected rewards. Engagement-contingent and completion-contingent rewards also significantly undermined self-reported interest (d = -0.15, and -0.17), as did all tangible rewards and all expected rewards. Positive feedback enhanced both free-choice behavior (d = 0.33) and self-reported interest (d = 0.31). Tangible rewards tended to be more detrimental for children than college students, and verbal rewards tended to be less enhancing for children than college students. The authors review 4 previous meta-analyses of this literature and detail how this study's methods, analyses, and results differed from the previous ones.


Asunto(s)
Control Interno-Externo , Motivación , Terapia Conductista , Conducta de Elección , Condicionamiento Operante , Humanos , Recompensa
14.
J Histochem Cytochem ; 37(4): 429-40, 1989 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2926121

RESUMEN

A glycoprotein of Mr 26-36,000 (SP-A) is an abundant phospholipid-associated protein in pulmonary surfactant. SP-A enhances phospholipid reuptake and inhibits secretion by Type II epithelial cells in vitro. We have used two electron microscopic cytochemical methods to demonstrate selective binding and uptake of SP-A by rat pulmonary Type II epithelial cells. Using an immunogold bridging technique, we showed that SP-A binding was selective for Type II cell surfaces. Binding was dose dependent and saturable, reaching maximal binding at approximately 10 ng/ml. On warming to 23 degrees C, SP-A binding sites were clustered in coated pits on the cell surface. To characterize the internalization and intracellular routing of SP-A, we used the biotinyl ligand-avidin-gold technique. Biotinyl SP-A was bound by rat Type II epithelial cells as described above. On warming, biotinyl SP-A was seen in association with coated vesicles and was subsequently located in endosomes and multivesicular bodies. Biotinyl SP-A-gold complexes were seen in close approximation to lamellar bodies 10-60 min after warming. Binding of biotinyl SP-A was inhibited by competition with unlabeled SP-A. These results support the concept that Type II epithelial cells bind and internalize SP-A by receptor-mediated endocytosis. This newly described uptake system may play a role in the recycling of surfactant components or mediate the actions of SP-A on surfactant phospholipid secretion.


Asunto(s)
Pulmón/metabolismo , Surfactantes Pulmonares/metabolismo , Animales , Biotina , Epitelio/metabolismo , Histocitoquímica/métodos , Pulmón/citología , Masculino , Microscopía Electrónica/métodos , Ratas , Ratas Endogámicas
15.
Pediatrics ; 105(3 Pt 1): 542-8, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10699107

RESUMEN

BACKGROUND: We previously demonstrated improved survival and early outcomes in a pilot trial of 2 doses of intravenous dexamethasone for infants with surfactant-treated respiratory distress syndrome. (1) A multicenter, randomized, double-blind trial was undertaken to confirm these results. METHODS: Infants <30 weeks' gestation were eligible if they had respiratory distress syndrome, required mechanical ventilation at 12 to 18 hours of age, and had received at least 1 dose of exogenous surfactant. Infants were excluded if sepsis or pneumonia was suspected or if congenital heart disease or chromosomal abnormalities were present. A total of 384 infants were enrolled-189 randomized to dexamethasone (.5mg/kg birth weight at 12-18 hours of age and a second dose 12 hours later) and 195 to an equal volume of saline placebo. RESULTS: No differences were found in the dexamethasone versus placebo groups, respectively, regarding the primary outcomes of survival (79% vs 83%), survival without oxygen at 36 weeks' corrected gestational age (CGA; both 59%), and survival without oxygen at 36 weeks' CGA and without late glucocorticoid therapy (46% vs 44%). No significant differences between the groups in estimates from Kaplan-Meier survival analyses were found for median days on oxygen (50 vs 56 days), ventilation (20 vs 27 days), days to regain birth weight (15.5 vs 14 days), or length of stay (LOS; 88 vs 89 days). Infants given early dexamethasone were less likely to receive later glucocorticoid therapy for bronchopulmonary dysplasia during their hospitalization (27% vs 35%). No clinically significant side effects were noted in the dexamethasone group, although there were transient elevations in blood glucose and blood pressure followed by a return to baseline by study day 10. Among infants who died (40 vs 33), there were no differences in the median days on oxygen, ventilation, nor LOS. However, in survivors (149 vs 162), the following were observed: median days on oxygen 37 versus 45 days, ventilation 14 versus 19 days, and LOS 79 versus 81 days, for the dexamethasone versus placebo groups, respectively. CONCLUSIONS: This dose of early intravenous dexamethasone did not reduce the requirement for oxygen at 36 weeks' CGA and survival was not improved. However, early dexamethasone reduced the use of later prolonged dexamethasone therapy, and among survivors, reduced the median days on oxygen and ventilation. We conclude that this course of early dexamethasone probably represents a near minimum dose for instituting a prophylactic regimen against bronchopulmonary dysplasia.


Asunto(s)
Displasia Broncopulmonar/prevención & control , Dexametasona/administración & dosificación , Glucocorticoides/administración & dosificación , Enfermedades Pulmonares Obstructivas/prevención & control , Síndrome de Dificultad Respiratoria del Recién Nacido/tratamiento farmacológico , Displasia Broncopulmonar/mortalidad , Dexametasona/efectos adversos , Femenino , Glucocorticoides/efectos adversos , Humanos , Lactante , Recién Nacido , Tiempo de Internación , Enfermedades Pulmonares Obstructivas/mortalidad , Masculino , Terapia por Inhalación de Oxígeno , Síndrome de Dificultad Respiratoria del Recién Nacido/mortalidad , Tasa de Supervivencia
16.
Am J Med Genet ; 56(1): 97-100, 1995 Mar 13.
Artículo en Inglés | MEDLINE | ID: mdl-7747796

RESUMEN

We describe an infant with a deletion of 8q21-->22 who had distinct clinical manifestations including minor facial anomalies, a congenital heart defect, a Dandy-Walker variant, and mild to moderate developmental delay. Her facial characteristics included small, wide-spaced eyes, asymmetric bilateral epicanthal folds, a broad nasal bridge, a "carp-shaped" mouth, micrognathia, and prominent, apparently low-set ears. Three other reports describe children with larger proximal deletions of 8q that include 8q21 and q22. These four children all have similar facial appearance. Of the others reported, one had a congenital heart defect and one had craniosynostosis. This case, in addition to the previously noted three cases, helps in delineating a recognizable syndrome.


Asunto(s)
Anomalías Múltiples/genética , Deleción Cromosómica , Cromosomas Humanos Par 8 , Síndrome de Dandy-Walker/genética , Cardiopatías Congénitas/genética , Adulto , Niño , Preescolar , Bandeo Cromosómico , Resultado Fatal , Femenino , Humanos , Recién Nacido , Masculino
17.
Obstet Gynecol ; 78(5 Pt 2): 897-9, 1991 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1923220

RESUMEN

Severe fetal hydrops was diagnosed at 34 weeks' gestation. Funipuncture revealed a normal 46,XX karyotype and a hematocrit of 20%. Cesarean delivery was performed. Neonatal blood testing showed blood type B positive, positive direct and indirect Coombs, and an anti-B antibody titer of 1:64. The maternal blood group was O positive with a titer of 1:65,536 immunoglobulin G (IgG) anti-B antibody (after inactivation of IgM anti-B antibody). This report documents a rare case of fetal hydrops resulting from ABO incompatibility with neonatal survival.


Asunto(s)
Sistema del Grupo Sanguíneo ABO , Incompatibilidad de Grupos Sanguíneos/complicaciones , Hidropesía Fetal/etiología , Complicaciones del Embarazo/sangre , Adulto , Anticuerpos Antiidiotipos/sangre , Incompatibilidad de Grupos Sanguíneos/sangre , Incompatibilidad de Grupos Sanguíneos/inmunología , Cesárea , Prueba de Coombs , Femenino , Hematócrito , Humanos , Hidropesía Fetal/epidemiología , Hidropesía Fetal/genética , Inmunoglobulina G/inmunología , Cariotipificación , Embarazo , Complicaciones del Embarazo/inmunología , Tercer Trimestre del Embarazo , Diagnóstico Prenatal
18.
Health Psychol ; 17(3): 269-76, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9619477

RESUMEN

Self-determination theory was applied to explore the motivational basis of adherence to long-term medication prescriptions. Adult outpatients with various diagnoses who had been on a medication for at least 1 month and expected to continue (a) completed questionnaires that assessed their autonomous regulation, other motivation variables, and perceptions of their physicians' support of their autonomy by hearing their concerns and offering choice; (b) provided subjective ratings of their adherence and a 2-day retrospective pill count during an interview with a clinical psychologist; and (c) provided a 14-day prospective pill count during a subsequent, brief telephone survey. LISREL analyses supported the self-determination model for adherence by confirming that patients' autonomous motivation for adherence did mediate the relation between patients' perceptions of their physicians' autonomy support and their own medication adherence.


Asunto(s)
Enfermedad Crónica/tratamiento farmacológico , Libertad , Control Interno-Externo , Cooperación del Paciente/psicología , Autocuidado/psicología , Adulto , Distribución de Chi-Cuadrado , Enfermedad Crónica/psicología , Estudios Transversales , Análisis Factorial , Femenino , Estado de Salud , Humanos , Funciones de Verosimilitud , Modelos Logísticos , Cuidados a Largo Plazo/psicología , Masculino , Persona de Mediana Edad , Modelos Psicológicos , North Carolina , Relaciones Médico-Paciente , Autoadministración/psicología
19.
Acad Med ; 74(9): 992-5, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10498090

RESUMEN

While some theories of human motivation focus exclusively on levels of motivation, self-determination theory argues that different types of motivators, even when the resulting motivation is high, will lead to very different outcomes. This theory differentiates between two primary kinds of motivation, controlled and autonomous. Controlled motivation depends either on explicit or implicit rewards or punishment or on people's internalized beliefs about what is expected of them. Learning in controlled situations, in which students act under pressure and anxiety, is likely to be rote, short-lived, and poorly integrated into students' long-term values and skills. In contrast, autonomous motivation, as its name implies, is personally endorsed and reflects what people find interesting and important. While controlled motivation involves compliance with pressures, autonomous motivation involves behaving with a sense of volition, agency, and choice. Autonomously motivated learning leads to better educational outcomes. There is evidence that medical students who learn in autonomy-supportive environments act in more autonomy-supportive ways in their interactions with patients. Because the reliable implementation of practice guidelines and physicians' use of an autonomy-supportive style have been associated with more positive health outcomes (particularly in the behavior-related areas of smoking cessation, weight loss, etc.), more autonomy-supportive medical education may result in more effective health care delivery.


Asunto(s)
Educación Médica , Libertad , Motivación , Logro , Humanos , Relaciones Médico-Paciente , Estudiantes de Medicina/psicología
20.
J Pers Soc Psychol ; 52(5): 890-8, 1987 May.
Artículo en Inglés | MEDLINE | ID: mdl-3585701

RESUMEN

Ninety-one fifth-grade children participated in a study that assessed the effects of motivationally relevant conditions and individual differences on emotional experience and performance on a learning task. Two directed-learning conditions, one controlling and one noncontrolling, were contrasted with each other and with a third nondirected, spontaneous-learning context. Both directed sets resulted in greater rote learning compared with the nondirected-learning condition. However, both the nondirected and the noncontrolling directed-learning sets resulted in greater interest and conceptual learning compared with the controlling set, presumably because they were more conducive to autonomy or an internal perceived locus of causality. Furthermore, children in the controlling condition experienced more pressure and evidenced a greater deterioration in rote learning over an 8-(+/- 1) day follow-up. Individual differences in children's autonomy for school-related activities as measured by the Self-Regulation Questionnaire (Connell & Ryan, 1985) also related to outcomes, with more self-determined styles predicting greater conceptual learning. Results are discussed in terms of the role of autonomy in learning and development and the issue of directed versus nondirected learning.


Asunto(s)
Desarrollo Infantil , Individualidad , Aprendizaje , Niño , Femenino , Humanos , Masculino , Motivación , Desarrollo de la Personalidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA